RLYB
Rallybio Corp
17.20$
+0.0%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | |
| – | – | – | – | – | 6,211.8% | 10.7% | |
| – | – | – | – | – | -6,111.8% | 89.3% | |
| – | – | – | – | – | 6,526.3% | 2,284.0% | |
| – | – | – | – | – | 2,881.3% | 1,669.6% | |
| – | – | – | – | – | 3,400.2% | 3,360.1% | |
| – | – | – | – | – | -9,511.9% | -3,270.9% | |
| – | – | – | – | – | -9,084.1% | -1,046.4% | |
| – | – | – | – | – | -352.0% | – | |
| – | – | – | – | – | -9,084.1% | -1,046.4% | |
| – | – | – | – | – | -9,491.4% | -3,260.1% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.